ENT: Nausea /Vomitting and Vertigo Drugs

The anti-emetic guidelines are currently in the process of being updated. Please note the following Drug Safety Update: Ondansetron: small increased risk of oral clefts following use in the first 12 weeks of pregnancy.

https://www.gov.uk/drug-safety-update/ondansetron-small-increased-risk-of-oral-clefts-following-use-in-the-first-12-weeks-of-pregnancy

Key documents

  • Due for review
    01 January 2020
  • Clinical support group
    • Brain and mental health
    • Cancer, Palliative Care, Pain and Older People
    • Gastroenterology
    • Ophthalmology and ENT
    • Women's and Sexual Health

Do you want to add this to your CPD record?

Did you find this page helpful?